Correlation Between UBS ETRACS and Innovator MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both UBS ETRACS and Innovator MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UBS ETRACS and Innovator MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UBS ETRACS and Innovator MSCI EAFE, you can compare the effects of market volatilities on UBS ETRACS and Innovator MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UBS ETRACS with a short position of Innovator MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of UBS ETRACS and Innovator MSCI.

Diversification Opportunities for UBS ETRACS and Innovator MSCI

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between UBS and Innovator is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding UBS ETRACS and Innovator MSCI EAFE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator MSCI EAFE and UBS ETRACS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UBS ETRACS are associated (or correlated) with Innovator MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator MSCI EAFE has no effect on the direction of UBS ETRACS i.e., UBS ETRACS and Innovator MSCI go up and down completely randomly.

Pair Corralation between UBS ETRACS and Innovator MSCI

Given the investment horizon of 90 days UBS ETRACS is expected to under-perform the Innovator MSCI. In addition to that, UBS ETRACS is 7.36 times more volatile than Innovator MSCI EAFE. It trades about -0.45 of its total potential returns per unit of risk. Innovator MSCI EAFE is currently generating about 0.22 per unit of volatility. If you would invest  2,920  in Innovator MSCI EAFE on June 5, 2025 and sell it today you would earn a total of  42.00  from holding Innovator MSCI EAFE or generate 1.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

UBS ETRACS   vs.  Innovator MSCI EAFE

 Performance 
       Timeline  
UBS ETRACS 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days UBS ETRACS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Etf's forward indicators remain rather sound which may send shares a bit higher in October 2025. The latest tumult may also be a sign of longer-term up-swing for the fund shareholders.
Innovator MSCI EAFE 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Innovator MSCI EAFE are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Innovator MSCI is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

UBS ETRACS and Innovator MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with UBS ETRACS and Innovator MSCI

The main advantage of trading using opposite UBS ETRACS and Innovator MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UBS ETRACS position performs unexpectedly, Innovator MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator MSCI will offset losses from the drop in Innovator MSCI's long position.
The idea behind UBS ETRACS and Innovator MSCI EAFE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios